BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26868519)

  • 1. A comparison of clinicopathological characteristics and long-term survival outcomes between symptomatic and screen-detected breast cancer in Japanese women.
    Inari H; Shimizu S; Suganuma N; Yoshida T; Nakayama H; Yamanaka T; Yamanaka A; Rino Y; Masuda M
    Breast Cancer; 2017 Jan; 24(1):98-103. PubMed ID: 26868519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics.
    Hofvind S; Holen Å; Aas T; Roman M; Sebuødegård S; Akslen LA
    Eur J Surg Oncol; 2015 Oct; 41(10):1417-22. PubMed ID: 26253193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer.
    Sosa JA; Diener-West M; Gusev Y; Choti MA; Lange JR; Dooley WC; Zeiger MA
    Ann Surg Oncol; 1998 Mar; 5(2):140-9. PubMed ID: 9527267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of screening on clinicopathological features and treatment for invasive breast cancer: results of two national surveys.
    Cutuli B; Dalenc F; Cottu PH; Gligorov J; Guastalla JP; Petit T; Amrate A
    Cancer Radiother; 2015 Aug; 19(5):295-302. PubMed ID: 26188735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast-conserving therapy versus modified radical mastectomy in the treatment of early breast cancer in Japan.
    Horiguchi J; Iino Y; Koibuchi Y; Yokoe T; Takei H; Yamakawa M; Nakajima T; Oyama T; Ando T; Ishida T; Endo K; Takai Y; Suzuki H; Fujii T; Yokomori T; Morishita Y
    Breast Cancer; 2002; 9(2):160-5. PubMed ID: 12016396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omitting completion axillary lymph node dissection after detection of sentinel node micrometastases in breast cancer: first results from the prospective SENOMIC trial.
    Andersson Y; Bergkvist L; Frisell J; de Boniface J
    Br J Surg; 2021 Sep; 108(9):1105-1111. PubMed ID: 34010418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surgical treatment and prognosis of ductal carcinoma in situ: 526 cases analysis].
    Zhu SJ; Chen XS; Wu JY; Huang O; He JR; Zhu L; Chen WG; Li YF; Fei XC; Shen KW
    Zhonghua Wai Ke Za Zhi; 2017 Feb; 55(2):114-119. PubMed ID: 28162210
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: results from a clinical series.
    Crispo A; Barba M; D'Aiuto G; De Laurentiis M; Grimaldi M; Rinaldo M; Caolo G; D'Aiuto M; Capasso I; Esposito E; Amore A; Di Bonito M; Botti G; Montella M
    BMC Cancer; 2013 Jan; 13():15. PubMed ID: 23305429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residual lymph node tumour burden following removal of a single axillary sentinel lymph with macrometastatic disease in women with screen-detected invasive breast cancer.
    Dave RV; Cheung S; Sibbering M; Kearins O; Jenkins J; Gandhi A
    BJS Open; 2021 Mar; 5(2):. PubMed ID: 33688940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.
    Krag DN; Anderson SJ; Julian TB; Brown AM; Harlow SP; Costantino JP; Ashikaga T; Weaver DL; Mamounas EP; Jalovec LM; Frazier TG; Noyes RD; Robidoux A; Scarth HM; Wolmark N
    Lancet Oncol; 2010 Oct; 11(10):927-33. PubMed ID: 20863759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related variations in the use of axillary dissection: a survival analysis of 8038 women with T1-ST2 breast cancer.
    Truong PT; Bernstein V; Wai E; Chua B; Speers C; Olivotto IA
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):794-803. PubMed ID: 12377331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of breast-conserving treatment for early-stage breast cancer in Japanese women from multicenter investigation.
    Ohsumi S; Sakamoto G; Takashima S; Koyama H; Shin E; Suemasu K; Nishi T; Nakamura S; Iino Y; Iwase T; Ikeda T; Teramoto S; Fukutomi T; Komaki K; Sano M; Sugiyama K; Miyoshi K; Kamio T; Ogita M
    Jpn J Clin Oncol; 2003 Feb; 33(2):61-7. PubMed ID: 12629055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast-conserving surgery in early-stage breast cancer (indications, local recurrences, survival, cosmetic results).
    Mitov FS; Molov VV
    Folia Med (Plovdiv); 2006; 48(1):23-30. PubMed ID: 16918051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Better predictive value of axillary lymph node (ALN) status after systemic therapy for operable HER2-overexpressing breast cancer: A single-institution retrospective study.
    Zhang Y; Mo M; Li JW; Zhou Y; Wu J; Yu KD; Shen ZZ; Shao ZM; Liu GY
    Eur J Surg Oncol; 2016 Aug; 42(8):1146-52. PubMed ID: 27365197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of mammographic breast cancer screening in Singapore: a comparison between screen-detected and symptomatic women.
    Wang WV; Tan SM; Chow WL
    Asian Pac J Cancer Prev; 2011; 12(10):2735-40. PubMed ID: 22320984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in subtype distribution between screen-detected and symptomatic invasive breast cancer and their impact on survival.
    Kobayashi N; Hikichi M; Ushimado K; Sugioka A; Kiriyama Y; Kuroda M; Utsumi T
    Clin Transl Oncol; 2017 Oct; 19(10):1232-1240. PubMed ID: 28409323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
    Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of operable invasive breast cancer in women over the age of 70: long-term results of a large-scale single-institution experience.
    Laki F; Kirova YM; Savignoni A; Campana F; Levu B; Estève M; Sigal-Zafrani B; Dorval T; Asselain B; Salmon RJ
    Ann Surg Oncol; 2010 Jun; 17(6):1530-8. PubMed ID: 20177798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes.
    Grills IS; Kestin LL; Goldstein N; Mitchell C; Martinez A; Ingold J; Vicini FA
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):658-70. PubMed ID: 12788171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical intervention in screen-detected patients versus symptomatic patients with breast cancer.
    Dillon MF; Hill AD; Quinn CM; O'Doherty A; Crown J; Fleming FJ; McDermott EW; O'Higgins N
    J Med Screen; 2004; 11(3):130-4. PubMed ID: 15333271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.